|
Video: What is a Stock Split?
|
|
Zosano Pharma is a clinical stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using its proprietary intracutaneous microneedle system (the System). Co.'s development activities are focused on its product candidate, Qtrypta (M207). Qtrypta (M207) is Co.'s proprietary formulation of zolmitriptan delivered utilizing its System. Zolmitriptan is one of a class of serotonin receptor agonists known as triptans and is used as an acute treatment for migraine. Qtrypta (M207) is designed for absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal tract. According to our ZSAN split history records, ZSAN has had 2 splits. | |
|
ZSAN (ZSAN) has 2 splits in our ZSAN split history database. The first split for ZSAN took place on January 26, 2018. This was a 1 for 20 reverse split, meaning for each 20 shares of ZSAN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split. ZSAN's second split took place on April 12, 2022. This was a 1 for 35 reverse split, meaning for each 35 shares of ZSAN owned pre-split, the shareholder now owned 1 share. For example, a 50 share position pre-split, became a 1.42857142857143 share position following the split.
When a company such as ZSAN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ZSAN split history from start to finish, an original position size of 1000 shares would have turned into 1.42857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ZSAN shares, starting with a $10,000 purchase of ZSAN, presented on a split-history-adjusted basis factoring in the complete ZSAN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/27/2015 |
|
End date: |
06/10/2022 |
|
Start price/share: |
$7,707.00 |
|
End price/share: |
$0.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.99% |
|
Average Annual Total Return: |
-72.57% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.72 |
|
Years: |
7.37 |
|
|
|
Date |
Ratio |
01/26/2018 | 1 for 20 | 04/12/2022 | 1 for 35 |
|
|